Alessandro Nencioni

Title: Innovations by Alessandro Nencioni

Introduction

Alessandro Nencioni is a notable inventor based in Lugano, Switzerland. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of oral solutions for steroid hormones. With a total of 2 patents to his name, Nencioni's work focuses on enhancing the bioavailability of these hormones, which is crucial for effective therapeutic applications.

Latest Patents

Nencioni's latest patents include innovative aqueous oral solutions of steroid hormones, specifically Progesterone and Testosterone, complexed with hydroxypropyl-β-cyclodextrin (HPβCD). These formulations are designed for oral administration and are characterized by a specific molar ratio that ensures high hormone plasma levels. The optimization of solubility, permeability, metabolic stability, and bioavailability allows for effective plasma concentrations following oral administration of lower doses compared to existing formulations on the market, such as Prometrium and Andriol. This advancement not only enhances patient safety but also improves compliance.

Career Highlights

Alessandro Nencioni is associated with Altergon SA, where he continues to innovate in the pharmaceutical sector. His work is pivotal in addressing the challenges of hormone delivery and improving treatment outcomes for patients.

Collaborations

Nencioni collaborates with talented professionals in his field, including Nadia Puppini and Alberto Bernareggi. Their combined expertise contributes to the success of their projects and the advancement of pharmaceutical technologies.

Conclusion

Alessandro Nencioni's contributions to the field of pharmaceutical formulations demonstrate his commitment to improving patient care through innovative solutions. His patents reflect a significant step forward in the administration of steroid hormones, showcasing the importance of research and development in healthcare.